Literature DB >> 33407331

Periarticular analgesic injection containing a corticosteroid after total hip arthroplasty may prevent deep venous thrombosis: a retrospective comparative cohort study.

Akira Hashimoto1, Motoki Sonohata2, Hirohito Hirata1, Shunsuke Kawano3, Shuichi Eto1, Masaya Ueno1, Masaaki Mawatari1.   

Abstract

BACKGROUND: Of late, periarticular analgesic injection (PAI) has become a common alternative treatment for pain following total hip arthroplasty (THA). However, the systemic effects of PAI containing corticosteroids in patients subjected to THA have not been investigated. This study evaluated the analgesic efficacy and systemic effects of PAI containing a corticosteroid in patients subjected to THA.
METHODS: This single-center, retrospective cohort study enrolled patients undergoing unilateral, primary THA. A total of 197 patients (200 hips) were included in the final analyses, with 87 hips in the PAI group and 113 hips in the control group. Numeric Rating Scale (NRS) and laboratory data were assessed preoperatively and on postoperative days (POD) 1 and 7. Pearson's correlation coefficients were obtained to assess the correlations between the D-dimer level on POD 7 and each outcome measure on POD 1.
RESULTS: The postoperative white blood cell count (WBC) was significantly higher in the PAI group than in the control group. Postoperative NRS, creatine phosphokinase (CK), and C-reactive protein (CRP) levels were significantly lower in the PAI group. D-dimer levels were significantly lower in the PAI group on POD 7. Postoperative aspartate transaminase (AST), alanine aminotransferase, blood urea nitrogen, and creatinine levels were within reference ranges. D-dimer levels on POD 7 showed a significant negative correlation with WBC on POD 1 (r=-0.4652) and a significant positive correlation with the NRS score and AST, CK, CRP, and D-dimer levels on POD 1 (r = 0.1558, 0.2353, 0.2718, 0.3545, and 0.3359, respectively).
CONCLUSIONS: PAI containing a corticosteroid may be an effective treatment for pain and inflammation after THA, and it does not seem to cause drug-induced liver or kidney injury. Moreover, corticosteroid PAI can may accelerate early ambulation, which prevents the elevation of postoperative D-dimer levels, and may reduce the risk of deep venous thrombosis.

Entities:  

Keywords:  Anti-inflammation; Corticosteroid; D-dimer; Periarticular analgesic injection; Total hip arthroplasty; Triamcinolone acetonide

Mesh:

Substances:

Year:  2021        PMID: 33407331      PMCID: PMC7786517          DOI: 10.1186/s12891-020-03879-x

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  50 in total

1.  Early mobilisation after conventional knee replacement may reduce the risk of postoperative venous thromboembolism.

Authors:  E O Pearse; B F Caldwell; R J Lockwood; J Hollard
Journal:  J Bone Joint Surg Br       Date:  2007-03

Review 2.  The operation of the century: total hip replacement.

Authors:  Ian D Learmonth; Claire Young; Cecil Rorabeck
Journal:  Lancet       Date:  2007-10-27       Impact factor: 79.321

3.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes.

Authors:  L C Meagher; J M Cousin; J R Seckl; C Haslett
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

Review 4.  Diagnosis and treatment of deep-vein thrombosis.

Authors:  Dimitrios Scarvelis; Philip S Wells
Journal:  CMAJ       Date:  2006-10-24       Impact factor: 8.262

5.  Can a periarticular levobupivacaine injection reduce postoperative opiate consumption during primary hip arthroplasty?

Authors:  Terence P Murphy; Damien P Byrne; Paul Curtin; Joseph F Baker; Kevin J Mulhall
Journal:  Clin Orthop Relat Res       Date:  2011-09-30       Impact factor: 4.176

Review 6.  Thromboembolic diseases: biochemical mechanisms and new possibilities of biological diagnosis.

Authors:  J Amiral; J Fareed
Journal:  Semin Thromb Hemost       Date:  1996       Impact factor: 4.180

7.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Authors:  Philip S Wells; David R Anderson; Marc Rodger; Melissa Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

8.  Periarticular infiltration for pain relief after total hip arthroplasty: a comparison with epidural and PCA analgesia.

Authors:  Ageliki Pandazi; Ilias Kanellopoulos; Konstantinos Kalimeris; Chrysanthi Batistaki; Nikolaos Nikolakopoulos; Paraskevi Matsota; George C Babis; Georgia Kostopanagiotou
Journal:  Arch Orthop Trauma Surg       Date:  2013-09-14       Impact factor: 3.067

9.  Single periarticular local infiltration analgesia reduces opiate consumption until 48 hours after total knee arthroplasty. A randomized placebo-controlled trial involving 56 patients.

Authors:  Mika Niemeläinen; Jarkko Kalliovalkama; Antti J Aho; Teemu Moilanen; Antti Eskelinen
Journal:  Acta Orthop       Date:  2014-09-19       Impact factor: 3.717

10.  Does local infiltration analgesia reduce peri-operative inflammation following total hip arthroplasty? A randomized, double-blind study.

Authors:  J Kuchálik; A Magnuson; E Tina; A Gupta
Journal:  BMC Anesthesiol       Date:  2017-05-03       Impact factor: 2.217

View more
  2 in total

1.  Dexamethasone Does not Compensate for Local Anesthetic Cytotoxic Effects on Tenocytes: Morphine or Morphine Plus Dexamethasone May Be a Safe Alternative.

Authors:  Anne Lene Oeyen; Jörn Kircher; Melanie Vogl; Irina Ickert; Nani Osada; Rüdiger Krauspe; Bernd Bittersohl; Monika Herten
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-12-23

2.  Comparison of the Effect of Different Local Analgesia Administration Techniques in Total Hip Arthroplasty: A Retrospective Comparative Cohort Study.

Authors:  Akira Hashimoto; Motoki Sonohata; Atsushi Kawaguchi; Sakumo Kii; Hirohito Hirata; Masaaki Mawatari
Journal:  Pain Res Manag       Date:  2021-07-24       Impact factor: 3.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.